Justin Kim
Stock Analyst at Oppenheimer
(4.34)
# 1,328
Out of 5,000 analysts
103
Total ratings
49.2%
Success rate
13.3%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Justin Kim
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| IONS Ionis Pharmaceuticals | Reiterated: Buy | $110 → $85 | $43.81 | +94.02% | 7 | Sep 24, 2026 | |
| ZURA Zura Bio | Reiterated: Buy | $15 → $16 | $4.16 | +284.62% | 4 | Jun 8, 2026 | |
| IMCR Immunocore Holdings | Reiterated: Buy | $85 → $86 | $31.32 | n/a | 10 | May 8, 2025 | |
| CYTK Cytokinetics | Reiterated: Buy | $54 → $96 | $65.66 | n/a | 10 | Feb 28, 2025 | |
| ALDX Aldeyra Therapeutics | Reiterated: Buy | $12 | $1.22 | n/a | 21 | Oct 3, 2024 | |
| VERA Vera Therapeutics | Reiterated: Buy | $34 | $33.34 | n/a | 1 | Jan 26, 2024 | |
| PHVS Pharvaris | Rated: Buy | $26 | $32.99 | n/a | 8 | Nov 10, 2023 | |
| AUPH Aurinia Pharmaceuticals | Reiterated: Hold | n/a | $16.60 | n/a | 28 | Aug 8, 2023 | |
| BCRX BioCryst Pharmaceuticals | Reiterated: Hold | n/a | $8.52 | n/a | 6 | Dec 15, 2022 | |
| ELTX Elicio Therapeutics | Downgraded: Hold | n/a | $1.88 | n/a | 8 | Jun 30, 2022 |
Ionis Pharmaceuticals
Sep 24, 2026
Reiterated: Buy
Price Target: $110 → $85
Current: $43.81
Upside: +94.02%
Zura Bio
Jun 8, 2026
Reiterated: Buy
Price Target: $15 → $16
Current: $4.16
Upside: +284.62%
Immunocore Holdings
May 8, 2025
Reiterated: Buy
Price Target: $85 → $86
Current: $31.32
Upside: n/a
Cytokinetics
Feb 28, 2025
Reiterated: Buy
Price Target: $54 → $96
Current: $65.66
Upside: n/a
Aldeyra Therapeutics
Oct 3, 2024
Reiterated: Buy
Price Target: $12
Current: $1.22
Upside: n/a
Vera Therapeutics
Jan 26, 2024
Reiterated: Buy
Price Target: $34
Current: $33.34
Upside: n/a
Pharvaris
Nov 10, 2023
Rated: Buy
Price Target: $26
Current: $32.99
Upside: n/a
Aurinia Pharmaceuticals
Aug 8, 2023
Reiterated: Hold
Price Target: n/a
Current: $16.60
Upside: n/a
BioCryst Pharmaceuticals
Dec 15, 2022
Reiterated: Hold
Price Target: n/a
Current: $8.52
Upside: n/a
Elicio Therapeutics
Jun 30, 2022
Downgraded: Hold
Price Target: n/a
Current: $1.88
Upside: n/a